Towards Healthcare Research & Consulting
Computational Biology Market
Updated Date: 10 July 2026   |   Report Code: 5177
[email protected] +1 804-441-9344
Download Sample Order Now

Computational Biology Market Size, Share, Trends, and Forecast Analysis 2035

According to Rohan Patil, who specializes in genomics and molecular modelling, drug discovery, data analytics, bioinformatics and genomic research, and precision biology data solutions, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the computational biology market. The global computational biology market size was estimated at USD 7.18 billion in 2025 and is predicted to increase from USD 8.13 billion in 2026 to approximately USD 24.81 billion by 2035, expanding at a CAGR of 13.20% from 2026 to 2035. His analysis highlights the increasing adoption of genomic data analysis tools, high-performance computing solutions, predictive biological analysis, and machine learning algorithms. The research also examines the competitive strategies of key industry participants, including QIAGEN, Illumina, Inc., Compugen, Fios Genomics and Thermo Fisher Scientific, Inc., shaping the future by advancing AI-driven biological research, accelerating precision medicine discovery, optimizing next-generation therapeutics, and strengthening precision healthcare solutions in the global computational biology market.

Last Updated : 10 July 2026 Category: Biotechnology Insight Code: 5177 Format: PDF / PPT / Excel

Content

Executive Summary

  • Overview of the Computational Biology Market
  • Key Market Trends and Insights
  • Market Dynamics and Drivers
  • Competitive Landscape
  • Future Outlook and Forecast

Introduction

  • Definition of Computational Biology
  • Scope of the Report
  • Methodology
  • Assumptions and Limitations

Market Overview

  • Market Segmentation
  • Market Size and Growth Analysis
  • Historical Market Trends

Market Segment Analysis

Market Segmentation by Service (Market Value and Volume)

  • Databases
    • Overview
    • Key Players
    • Market Trends and Insights
  • Infrastructure & Hardware
    • Overview
    • Key Players
    • Market Trends and Insights
  • Software Platform
    • Overview
    • Key Players
    • Market Trends and Insights

Market Segmentation by Application (Market Value and Volume)

  • Drug Discovery & Disease Modelling
    • Target Identification
      • Overview
      • Key Players
      • Market Trends and Insights
    • Target Validation
      • Overview
      • Key Players
      • Market Trends and Insights
    • Lead Discovery
      • Overview
      • Key Players
      • Market Trends and Insights
    • Lead Optimization
      • Overview
      • Key Players
      • Market Trends and Insights
    • Preclinical Drug Development
      • Overview
      • Key Players
      • Market Trends and Insights
  • Pharmacokinetics
    • Overview
    • Key Players
    • Market Trends and Insights
  • Pharmacodynamics
    • Overview
    • Key Players
    • Market Trends and Insights
  • Clinical Trial
    • Phase I
      • Overview
      • Key Players
      • Market Trends and Insights
    • Phase II
      • Overview
      • Key Players
      • Market Trends and Insights
    • Phase III
      • Overview
      • Key Players
      • Market Trends and Insights
    • Phase IV
      • Overview
      • Key Players
      • Market Trends and Insights
  • Computational Genomics
    • Overview
    • Key Players
    • Market Trends and Insights
  • Computational Proteomics
    • Overview
    • Key Players
    • Market Trends and Insights
  • Others
    • Overview
    • Key Players
    • Market Trends and Insights

Market Segmentation by Region (Market Value and Volume)

  • North America
    • U.S.
      • Market Size and Forecast
      • Key Trends and Insights
    • Canada
      • Market Size and Forecast
      • Key Trends and Insights
  • Europe
    • UK
      • Market Size and Forecast
      • Key Trends and Insights
    • Germany
      • Market Size and Forecast
      • Key Trends and Insights
    • France
      • Market Size and Forecast
      • Key Trends and Insights
    • Italy
      • Market Size and Forecast
      • Key Trends and Insights
    • Spain
      • Market Size and Forecast
      • Key Trends and Insights
    • Russia
      • Market Size and Forecast
      • Key Trends and Insights
    • Denmark
      • Market Size and Forecast
      • Key Trends and Insights
    • Sweden
      • Market Size and Forecast
      • Key Trends and Insights
    • Norway
      • Market Size and Forecast
      • Key Trends and Insights
  • Asia Pacific
    • Japan
      • Market Size and Forecast
      • Key Trends and Insights
    • China
      • Market Size and Forecast
      • Key Trends and Insights
    • India
      • Market Size and Forecast
      • Key Trends and Insights
    • South Korea
      • Market Size and Forecast
      • Key Trends and Insights
    • Australia
      • Market Size and Forecast
      • Key Trends and Insights
    • Singapore
      • Market Size and Forecast
      • Key Trends and Insights
    • Thailand
      • Market Size and Forecast
      • Key Trends and Insights
  • Latin America
    • Brazil
      • Market Size and Forecast
      • Key Trends and Insights
    • Mexico
      • Market Size and Forecast
      • Key Trends and Insights
    • Argentina
      • Market Size and Forecast
      • Key Trends and Insights
  • Middle East & Africa
    • South Africa
      • Market Size and Forecast
      • Key Trends and Insights
    • Saudi Arabia
      • Market Size and Forecast
      • Key Trends and Insights
    • UAE
      • Market Size and Forecast
      • Key Trends and Insights
    • Kuwait
      • Market Size and Forecast
      • Key Trends and Insights

Cross-Segment Analysis

  • Service by Application
    • Databases
      • Drug Discovery & Disease Modelling
        • Target Identification
        • Target Validation
        • Lead Discovery
        • Lead Optimization
      • Preclinical Drug Development
        • Pharmacokinetics
        • Pharmacodynamics
      • Clinical Trial
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Computational Genomics
      • Computational Proteomics
      • Others
    • Infrastructure & Hardware
      • Drug Discovery & Disease Modelling
        • Target Identification
        • Target Validation
        • Lead Discovery
        • Lead Optimization
        • Preclinical Drug Development
      • Pharmacokinetics
      • Pharmacodynamics
      • Clinical Trial
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Computational Genomics
      • Computational Proteomics
      • Others
    • Software Platform
      • Drug Discovery & Disease Modelling
        • Target Identification
        • Target Validation
        • Lead Discovery
        • Lead Optimization
        • Preclinical Drug Development
      • Pharmacokinetics
      • Pharmacodynamics
      • Clinical Trial
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Computational Genomics
      • Computational Proteomics
      • Others
  • Service by Region
    • Databases
      • North America
        • U.S.
        • Canada
      • Europe
        • UK
        • Germany
        • France
        • Italy
        • Spain
        • Russia
        • Denmark
        • Sweden
        • Norway
      • Asia Pacific
        • Japan
        • China
        • India
        • South Korea
        • Australia
        • Singapore
        • Thailand
      • Latin America
        • Brazil
        • Mexico
        • Argentina
      • Middle East & Africa
        • South Africa
        • UAE
        • Saudi Arabia
        • Kuwait
    • Infrastructure & Hardware
      • North America
        • U.S.
        • Canada
      • Europe
        • UK
        • Germany
        • France
        • Italy
        • Spain
        • Russia
        • Denmark
        • Sweden
        • Norway
      • Asia Pacific
        • Japan
        • China
        • India
        • South Korea
        • Australia
        • Singapore
        • Thailand
      • Latin America
        • Brazil
        • Mexico
        • Argentina
      • Middle East & Africa
        • South Africa
        • UAE
        • Saudi Arabia
        • Kuwait
    • Software Platform
      • North America
        • U.S.
        • Canada
      • Europe
        • UK
        • Germany
        • France
        • Italy
        • Spain
        • Russia
        • Denmark
        • Sweden
        • Norway
      • Asia Pacific
        • Japan
        • China
        • India
        • South Korea
        • Australia
        • Singapore
        • Thailand
      • Latin America
        • Brazil
        • Mexico
        • Argentina
      • Middle East & Africa
        • South Africa
        • UAE
        • Saudi Arabia
        • Kuwait
  • Application by Region
    • Drug Discovery & Disease Modelling
      • North America
        • U.S.
        • Canada
      • Europe
        • UK
        • Germany
        • France
        • Italy
        • Spain
      • Asia Pacific
        • China
        • India
        • Japan
        • South Korea
      • Latin America
        • Brazil
        • Mexico
      • Middle East & Africa
        • South Africa
        • UAE
    • Pharmacokinetics and Pharmacodynamics
      • North America
        • U.S.
        • Canada
      • Europe
        • UK
        • Germany
        • France
        • Italy
        • Spain
      • Asia Pacific
        • China
        • India
        • Japan
        • South Korea
      • Latin America
        • Brazil
        • Mexico
      • Middle East & Africa
        • South Africa
        • UAE
    • Clinical Trial
      • North America
        • U.S.
        • Canada
      • Europe
        • UK
        • Germany
        • France
        • Italy
        • Spain
      • Asia Pacific
        • China
        • India
        • Japan
        • South Korea
      • Latin America
        • Brazil
        • Mexico
      • Middle East & Africa
        • South Africa
        • UAE
    • Computational Genomics and Proteomics
      • North America
        • U.S.
        • Canada
      • Europe
        • UK
        • Germany
        • France
        • Italy
        • Spain
      • Asia Pacific
        • China
        • India
        • Japan
        • South Korea
      • Latin America
        • Brazil
        • Mexico
      • Middle East & Africa
        • South Africa
        • UAE

Go-to-Market Strategies

  • Market Penetration and Expansion
    • Focus on High-Growth Regions
    • Strengthen Presence in Emerging Markets
  • Strategic Partnerships and Alliances
    • Collaborate with Research Institutions
    • Leverage Pharmaceutical and Biotech Companies
  • Product and Service Differentiation
    • Innovative Solutions
    • Customization and Flexibility
  • Technology and Innovation Focus
    • Invest in R&D
    • Adopt Emerging Technologies
  • Sales and Marketing Strategy
    • Targeted Marketing Campaigns
    • Educational Outreach
  • Customer Engagement and Support
    • Enhanced Customer Support
    • Feedback Mechanisms
  • Regulatory and Compliance Strategy
    • Ensure Compliance
    • Certifications and Accreditations
  • Competitive Positioning
    • Market Analysis and Intelligence
    • Unique Value Proposition
  • Expansion of Service Offerings
    • Diversify Applications
    • Integrated Solutions
  • Pricing Strategy
    • Competitive Pricing
    • Flexible Pricing Models

Plan Finances/ROI Analysis

  • Budget Allocation
    • Service Development Costs
    • Marketing and Sales Expenses
    • Operational Costs
  • Revenue Projections
    • Short-Term Revenue Forecast
    • Long-Term Revenue Forecast
    • Revenue by Service Type
  • Cost Analysis
    • Fixed Costs
    • Variable Costs
    • Cost of Goods Sold (COGS)
  • Return on Investment (ROI)
    • ROI Calculation Methodology
    • Expected ROI by Service
    • ROI by Region
  • Break-Even Analysis
    • Break-Even Point Calculation
    • Time to Break-Even
  • Financial Metrics
    • Profit Margins
    • Gross Margin Analysis
    • Net Profit Margin
  • Investment Requirements
    • Initial Capital Investment
    • Funding Sources
    • Investment Milestones
  • Risk Analysis
    • Financial Risks
    • Mitigation Strategies
  • Financial Forecasts
    • Quarterly and Annual Projections
    • Sensitivity Analysis
  • Performance Tracking
    • Key Performance Indicators (KPIs)
    • Financial Performance Metrics
    • Reporting and Review Mechanisms

Integration of AI in the Computational Biology Market

  • Introduction
    • Overview of AI Integration in Computational Biology
    • Importance and Impact of AI
  • AI Technologies Used
    • Machine Learning
    • Deep Learning
    • Natural Language Processing
    • Computer Vision
  • Applications of AI in Computational Biology
    • Drug Discovery
      • Target Identification
      • Lead Discovery and Optimization
    • Disease Modelling
    • Genomic Data Analysis
      • Sequencing Data Analysis
      • Mutation Prediction
    • Proteomics
      • Protein Structure Prediction
      • Interaction Prediction
    • Personalized Medicine
    • Clinical Trials
      • Patient Stratification
      • Predictive Modeling
  • Benefits of AI Integration
    • Enhanced Data Analysis and Interpretation
    • Increased Accuracy and Efficiency
    • Accelerated Drug Development
    • Improved Disease Prediction and Prevention
  • Implementation Strategies
    • AI Infrastructure and Tools
    • Integration with Existing Computational Platforms
    • Data Management and Quality Control
    • Collaboration with Research Institutions
  • Challenges and Solutions
    • Data Privacy and Security
    • Handling Large and Complex Data Sets
    • Algorithmic Bias and Fairness
    • Integration and Scalability Issues
  • Case Studies and Examples
    • Successful AI Integration Projects
    • Key Learnings from Implementations
  • Future Trends
    • Emerging AI Technologies in Computational Biology
    • Potential Innovations and Developments
    • Long-Term Market Impact and Opportunities

Production and Consumption Data

  • Production Data
    • Production Overview
    • Production by Region
    • Production by Type
    • Production Trends
  • Consumption Data
    • Consumption Overview
    • Consumption by Region
    • Consumption by Type
    • Consumption Trends
  • Comparative Analysis
    • Production vs. Consumption
    • Regional Disparities
    • Historical Data and Forecasts
  • Factors Influencing Production and Consumption
    • Economic Factors
    • Technological Advancements
    • Market Demand and Supply
    • Regulatory Impacts
  • Data Sources and Methodology
    • Data Collection Methods
    • Sources of Data
    • Data Validation and Accuracy

Opportunity Assessment

  • Market Overview
    • Market Size and Growth
    • Key Market Trends
    • Competitive Landscape
  • Identification of Opportunities
    • Emerging Market Segments
    • Technological Advancements
    • Regulatory Changes
    • Consumer Behavior Shifts
  • Opportunity Evaluation
    • Market Potential and Demand
    • Competitive Advantage
    • Investment Feasibility
    • Risk and Reward Analysis
  • Strategic Fit
    • Alignment with Company Goals
    • Synergies with Existing Capabilities
    • Resource Requirements
  • Financial Analysis
    • Revenue Potential
    • Cost Implications
    • Return on Investment (ROI)
    • Break-Even Analysis
  • Action Plan
    • Short-Term Actions
    • Long-Term Strategies
    • Resource Allocation
    • Milestones and Metrics

Competitive Landscape

  • Key Market Players
    • Fios Genomics
      • Market Share Analysis
      • Strategic Initiatives
      • Mergers and Acquisitions
      • Product and Service Innovations
    • Xaira Therapeutics
    • Seed Health
    • Simulations Plus, Inc.
    • QIAGEN
    • Genedata AG
    • Aganitha AI Inc.
    • Compugen
    • Schrodinger, Inc.
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • DNAnexus, Inc.
  • Emerging Technologies and Innovations
  • Market Opportunities and Challenges
  • Future Market Forecast

Appendix

  • Glossary of Terms
  • List of Abbreviations
  • References
  • Additional Resources

FAQ's

Answer : Systems biology, genomes, neuroscience, biological networks, population dynamics and molecular modeling are some of the applications of computational biology.

Answer : No. Both the disciples are closely related and are often used interchangeably. However, they both have several differences.

Answer : National Institutes of Health, Pacific Northwest National Laboratory, Genomic Science Program, International Society of Computational Biology, Department of Biotechnology.
Any Questions

Meet the Team

Rohan Patil is a seasoned market research professional with over 5+ years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

Learn more about Rohan Patil

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar